Analysis of Involvement of Cytokine Genetic Polymorphisms in Development of Genital Endometriosis by Churnosov, M. I. et al.
          ISSN: 0975-8585 
September - October 2014  RJPBCS   5(5)  Page No. 1027 
Research Journal of Pharmaceutical, Biological and Chemical 
Sciences 
 
Analysis of Involvement of Cytokine Genetic Polymorphisms in Development 
of Genital Endometriosis.  
 
 
Churnosov Mihail Ivanovich*, Oksana Borisovna Altuchova, Natalia Aleksandrovna 
Demakova, Evdokimov Valeriy Ivanovich, and Sorokina Inna Nikolaevna. 
 
Belgorod National Research University, 85 Pobedy St., Belgorod, 308015 Russia. 
 
 
 
 
 
ABSTRACT 
 
The article outlines the role of cytokines in development of genital endometriosis. There were 
detected associations between genetic polymorphisms IL-6 c.-237 C>G (rs1800795), SDF-1 c.*519 G>A 
(rs1801157), MIP-1в c.*524 A>T (rs1719153), IL-10 c.-627 A>C (rs180082), RANTES c.- 471 G>A (rs 2107538), IL-
1в c.-598 T>C (rs16944) and I-TAC c.*1539 T>C (rs4512021) and their combinations and development of genital 
endometriosis among women in the Central region of Russia.     
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INTRODUCTION 
 
Genital endometriosis is a pathologic process which is characterized by benign growth of tissue 
beyond the uterine cavity which by its morphological and functional properties is similar to endometrium [1]. 
In the structure of gynecological incidence genital endometriosis holds the third place after inflammatory 
diseases and uterine leiomyoma.  
 
The most contemporary theories state that endometrial stroma and glands formation is being 
influenced by genetic, paracrine and immunologic factors [2]. In this connection a considerable number of 
works are dedicated to study of genetic principles of endometriosis development [3, 4]. Nevertheless it is 
worth mentioning that the results obtained by different groups of investigators are contradictory and do not 
give an unambiguous answer to the question about the role of genetic factors in pathogenesis and clinical 
features of genital endometriosis. In view of the above this work studies the role of cytokine genetic 
polymorphisms IL-6 c.-237 C>G (rs1800795), IL-1в c.-598 T>C (rs16944), IL-1б c.-949 C>T (rs1800587), IL-4 c.-
589 C>T (rs2243250), IL-10 c.-627 A>C (rs180082), IL-5 c. -746 T>C (rs2069812), SDF-1 c.*519 G>A (rs1801157), 
IL-8 c.-352 A>T (rs4073), MIP-1в c.*524 A>T (rs1719153), RANTES c.- 471 G>A (rs 2107538), MCP-1 c.77-109 
G>C (rs2857657) and I-TAC c.*1539 T>C (rs4512021) in development of genital endometriosis. 
 
MATERIALS AND METHODS 
 
There was performed analysis of the observation data for 604 persons: 104 patients with genital 
endometriosis and 500 females from the reference panel. The patients and reference panels included Russian 
women, natives of the Central region of Russia and not having family ties among themselves. Clinical 
laboratory examination of the patients was performed at the gynecology department of the perinatal center of 
the Bishop Ioasaf Belgorod Regional Clinical Hospital. The patients with genital endometriosis were subject to 
pelvic organs ultrasonography, hysteroscopy with the subsequent directional biopsy of the lining of the uterus 
and histologic examination of the scrape, the procedures were performed by means of the common and 
laboratory methods of examination. 
 
All of the patients with genital endometriosis and individuals from the reference panel were subject 
to typing of single nucleotide polymorphisms of cytokine genes - IL-6 c.-237 C>G (rs1800795), IL-1в c.-598 T>C 
(rs16944), IL-1б c.-949 C>T (rs1800587), IL-4 c.-589 C>T (rs2243250), IL-10 c.-627 A>C (rs180082), IL-5 c. -746 
T>C (rs2069812) SDF-1 c.*519 G>A (rs1801157), IL-8 c.-352 A>T (rs4073), MIP-1в c.*524 A>T (rs1719153), 
RANTES c.- 471 G>A (rs 2107538), MCP-1 c.77-109 G>C (rs2857657) and I-TAC c.*1539 T>C (rs4512021). 
 
Venous blood samples with the volume of 8-9 ml drawn from the ulnar vein of the proband were used 
as a test material. Genomic DNA extraction from peripheral blood was performed by the standard method of 
phenol-chloroform extraction from frozen venous blood samples. [5]. Analysis of the examined loci was carried 
out by the method of polymerase chain reaction of DNA synthesis with use of oligonucleotide primers and 
probes [6-8]. Associations of alleles and genotypes of the studied DNA-markers with development of genital 
endometriosis were assessed by means of analysis of 2x2 contingency tables which included calculation of 
2  
test with Yates' correction for continuity and odds ratio (OR) with 95% confidence interval. Analysis of the role 
of combination of cytokine genetic variations in genital endometriosis onset was carried out with the help of 
APSampler software [9]. 
 
RESULTS 
 
The analysis of allelic frequencies of the examined polymorphic markers of genes revealed that for all 
of the studied loci in the panel with the patients having genital endometriosis and in the sampling population 
the observable distribution of genotypes complied with theoretical expectations at Hardy–Weinberg 
equilibrium (p>0.05) (Table 1).   
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Table 1: Summary information about the studied polymorphisms. 
 
Polymorphism Studied 
groups 
Minor allele MAF (%) HWE 
2  p 
IL-1б c.-949 C>T (rs1800587) Case Т 21.50 0.67 >0.05 
IL-1б c.-949 C>T (rs1800587) Control Т 20.40 1.31 >0.05 
IL-1в c.-598 T>C (rs16944) Case Т 32.50 0.004 >0.05 
IL-1в c.-598 T>C (rs16944) Control Т 34.58 0.25 >0.05 
IL-4 c.-589 C>T (rs2243250) Case Т 21.05 0.56 >0.05 
IL-4 c.-589 C>T (rs2243250) Control Т 18.87 0.19 >0.05 
IL-5 c.-746 T>C (rs2069812) Case T 25.34 0.007 >0.05 
IL-5 c.-746 T>C (rs2069812) Control T 27.59 0,004 >0.05 
IL-6 c.-237 C>G (rs1800795) Case С 47.06 1.51 >0.05 
IL-6 c.-237 C>G (rs1800795) Control С 44.63 0.01 >0.05 
IL-10 c.-627 A>C (rs180082) Case A 27.38 3.27 >0.05 
IL-10 c.-627 A>C (rs180082) Control A 24.44 1.42 >0.05 
IL-8 c.-352 A>T (rs4073) Case A 46.00 2.39 >0.05 
IL-8 c.-352 A>T (rs4073) Control A 48.76 0.94 >0.05 
RANTES c.- 471 G>A (rs 2107538) Case A 16.16 0.19 >0.05 
RANTES c.- 471 G>A (rs 2107538) Control A 17.95 0.17 >0.05 
I-TAC c.*1539 T>C (rs4512021) Case С 42.35 0.06 >0.05 
I-TAC c.*1539 T>C (rs4512021) Control С 44.15 0.07 >0.05 
MIP-1в c.*524 A>T (rs1719153) Case T 27.92 0.32 >0.05 
MIP-1в c.*524 A>T (rs1719153) Control T 27.27 1.44 >0.05 
MCP-1 c.77-109 G>C (rs2857657) Case G 18.04 1.60 >0.05 
MCP-1 c.77-109 G>C (rs2857657) Control G 16.87 0.93 >0.05 
SDF-1 c.*519 G>A (rs1801157) Case A 23.23 1.74 >0.05 
SDF-1 c.*519 G>A (rs1801157) Control A 17.02 0.01 >0.05 
Notes: MAF, minor allele frequency; HWE, Hardy–Weinberg equilibrium. P values were calculated using the 
2  test. 
 
It was ascertained that the patients with genital endometriosis demonstrated high frequency of allele 
А SDF-1 (23.23%) as compared to the reference group (17.02%, чІ=3.86, р=0.05, OR=1.47, 95% CI 1.00 – 2.17).  
 
Bioinformatic approaches allowed to reveal that the following combinations of genetic variations of 
cytokines are involved in development of genital endometriosis: C IL-6, A SDF-1, A MIP-1в and C IL-10 
(OR=5.02); A SDF-1, G RANTES, A MIP-1в фтв C IL-10 (OR=4.00); A SDF-1, G RANTES, C IL-1в, C IL-10 (OR=3.55); 
A SDF-1, A MIP-1в, C IL-10 (OR=3.32), C IL-6, A SDF1, G RANTES, C IL-10 (OR=3.70), A SDF-1, A I-TAC, CC IL-1в 
(OR=3.76) (Table 2). 
 
          ISSN: 0975-8585 
September - October 2014  RJPBCS   5(5)  Page No. 1030 
Table 2: Concentration combinations of alleles/genotypes of cytokine genes in patients with genital 
endometriosis and in the reference panel 
 
SNP 1 SNP 2 SNP 3 SNP 4 Carriage Fisher's p-value 
(Bonferroni 
correction, рcor) 
Permutation test, 
рperm 
Odds ratio (95% CI) 
Case Control 
C IL-6 A SDF1 A MIP1в C IL-10 40.00 11.72 0.0000008 
(0.0073) 
0.0000003 
5.02 (2.52-10.01) 
A SDF1 G RANTES A MIP1в C IL-10 49.18 19.44 0.000001 
(0.01) 
0.000008 
4.00 (2.15-7.47) 
A SDF1 G RANTES C IL-1в C IL-10 41.77 16.77 0.000004 
(0.03) 
0.0001 
3.55 (1.92-6.57) 
A SDF1 A MIP1в C IL-10  48.38 22.00 0.000005 
(0.04) 
0.0001 
3.32 (1.85-5.94) 
C IL-6 A SDF1 G RANTES C IL-10 37.31 13.84 0.000006 
(0.05) 
0.0004 
3.70 (1.95-7.02) 
A SDF1 А I-TAC СC IL-1в  24.73 8.03 0.000008 
(0.05) 
0.0005 
3.76 (1.95-7.25) 
 
CONCLUSION 
 
The work contains evidences that allele А SDF-1 is associated with development of genital 
endometriosis (OR=1.47). It ought to be noted that allele А SDF-1 is comprised in all combinations of genetic 
variations of cytokines associated with elevated risk of genital endometriosis development. According to the 
literature sources SDF1 functions as a stimulator of angiogenesis due to increased synthesis of VEGF (vascular 
endothelial growth factor), and simultaneously encourages cells survival through apoptosis inactivation by 
means of apoptosis regulator BСl-2, which forms the basis of genital endometriosis pathogenesis. Other 
chemokines (RANTES, MIP-1в and I-TAC) according to literature evidences [10] are involved in the 
inflammatory reactions processes connected with genital endometriosis. In such situation the content of 
proinflammatory chemokines in peritoneal fluid grows significantly thus counteracting the opportunity to 
attract immunocompetent and other cells which detect inflammatory reaction to the focus of heterotopias 
formation and development.    
 
Nosotropic significance of genetic polymorphisms IL-6 c.-237 C>G (rs1800795), IL-1в c.-598 T>C 
(rs16944) and IL-10 c.-627 A>C (rs180082) for genital endometriosis formation discovered by our investigation 
complies with literature evidence stating their medical and biological effects. Thus in case of endometriosis the 
concentration of IL-1в and IL-6 (which are mainly produced by macrophages) in peritoneal fluid increases. In its 
turn IL-1в and IL-6 affect the processes of differentiation and growth of cells inclusive of ovarian and 
endometrial cells. The literature sources state positive association of polymorphism IL-10 c.-627 A>C 
(rs180082) with genital endometriosis [11]. The authors mention that presence of allele C of polymorphism IL-
10 c.-627 A>C (rs180082) in genotype may account for increase of production of anti-inflammatory IL-10 which 
is accompanied by suppression of T-lymphocytes proliferation and reduction of level of cytokines of Th1 
response. This promotes growth and invasion of new endometrioid heterotopias. 
 
FINDINGS 
 
 Therefore the results of work allow making a conclusion that allele А SDF-1 is associated with genital 
endometriosis development. Combinations of genetic variations C IL-6, A SDF-1, A MIP-1в and C IL-10 
(OR=5.02); A SDF-1, G RANTES, A MIP-1в and  C IL-10 (OR=4.00); A SDF-1, G RANTES, C IL-1в, C IL-10 (OR=3.55); 
A SDF-1, A MIP-1в, C IL-10 (OR=3.32), C IL-6, A SDF1, G RANTES, C IL-10 (OR=3.70), A SDF-1, A I-TAC, CC IL-1в 
(OR=3.76) are risk factors for genital endometriosis development. 
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